SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vestor who wrote (1041)6/24/1997 4:31:00 PM
From: I. Luttichuys   of 1762
 
Hello Vestor,
I have to be the first to admit that the near term might be a little murky but, I was very tempted to buy this morning. After the initial reaction, I was surprised at the strength of support. Seems to hint strongly that anticipated revenues from C2B8 and market enthusiasm for same are what put us at these levels. Doesn't seem from most analysts projections (at least for the near term) that CE9.1 was too heavily factored in.
If I do see strength in the coming days, I may accumulate by splitting my play money into 4 to 8 equal lots, buying arbitrarily at whatever I see it at when I first buy and then catching it on each weakness after that as I suspect the current share price is justifiable if C2B8 is marketed, perhaps more. I would expect the stock will run up into the approval as often happens.
When I buy my first lot, I will post.
That could be soon because I have to say it again... I thought the stock would react more seriously than this and, I see this as favourable... surprising stability and that is probably due to C2B8 promise.
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext